LU88175A1 - Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer - Google Patents

Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer Download PDF

Info

Publication number: LU88175A1
Authority: LU; Luxembourg
Prior art keywords: ppm; deuterium; water; deuterium content; content
Prior art date: 1991-10-31

Application number

LU88175A

Other languages

English (en)

French (fr)

Inventor

Gabor Somlyai

Original Assignee

Gabor Somlyai

D For H Alapitvany Az Egeszseg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-31

Filing date

1992-09-24

Publication date

1993-03-15

1992-09-24 Application filed by Gabor Somlyai, D For H Alapitvany Az Egeszseg filed Critical Gabor Somlyai

1993-03-15 Publication of LU88175A1 publication Critical patent/LU88175A1/fr

Links

206010028980 Neoplasm Diseases 0.000 title claims description 36
238000004519 manufacturing process Methods 0.000 title claims description 14
239000000825 pharmaceutical preparation Substances 0.000 title claims description 12
229940127557 pharmaceutical product Drugs 0.000 title claims description 12
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 9
YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 106
229910052805 deuterium Inorganic materials 0.000 claims description 106
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 58
238000000034 method Methods 0.000 claims description 34
239000000243 solution Substances 0.000 claims description 17
230000008569 process Effects 0.000 claims description 13
235000013405 beer Nutrition 0.000 claims description 11
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
241000282414 Homo sapiens Species 0.000 claims description 8
239000007864 aqueous solution Substances 0.000 claims description 8
239000002674 ointment Substances 0.000 claims description 8
239000002671 adjuvant Substances 0.000 claims description 7
235000020357 syrup Nutrition 0.000 claims description 7
239000006188 syrup Substances 0.000 claims description 7
238000004821 distillation Methods 0.000 claims description 6
239000003814 drug Substances 0.000 claims description 6
238000005868 electrolysis reaction Methods 0.000 claims description 6
239000013543 active substance Substances 0.000 claims description 5
235000013399 edible fruits Nutrition 0.000 claims description 5
230000003020 moisturizing effect Effects 0.000 claims description 4
239000002504 physiological saline solution Substances 0.000 claims description 4
239000000969 carrier Substances 0.000 claims description 3
235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
239000003978 infusion fluid Substances 0.000 claims description 2
230000001476 alcoholic effect Effects 0.000 claims 1
229940102223 injectable solution Drugs 0.000 claims 1
241001465754 Metazoa Species 0.000 description 25
210000004027 cell Anatomy 0.000 description 24
238000002474 experimental method Methods 0.000 description 13
239000000047 product Substances 0.000 description 12
230000000694 effects Effects 0.000 description 10
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 9
230000004663 cell proliferation Effects 0.000 description 9
229910052739 hydrogen Inorganic materials 0.000 description 9
239000001257 hydrogen Substances 0.000 description 9
239000011734 sodium Substances 0.000 description 9
230000012010 growth Effects 0.000 description 8
241000699670 Mus sp. Species 0.000 description 7
201000010099 disease Diseases 0.000 description 7
239000000203 mixture Substances 0.000 description 7
230000004913 activation Effects 0.000 description 6
239000012153 distilled water Substances 0.000 description 6
238000012360 testing method Methods 0.000 description 6
238000002054 transplantation Methods 0.000 description 6
241000196324 Embryophyta Species 0.000 description 5
235000008504 concentrate Nutrition 0.000 description 5
239000012141 concentrate Substances 0.000 description 5
230000001965 increasing effect Effects 0.000 description 5
230000003834 intracellular effect Effects 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
235000021559 Fruit Juice Concentrate Nutrition 0.000 description 4
241000699666 Mus <mouse, genus> Species 0.000 description 4
240000004808 Saccharomyces cerevisiae Species 0.000 description 4
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
239000003651 drinking water Substances 0.000 description 4
235000020188 drinking water Nutrition 0.000 description 4
235000015203 fruit juice Nutrition 0.000 description 4
239000002609 medium Substances 0.000 description 4
230000035755 proliferation Effects 0.000 description 4
230000001225 therapeutic effect Effects 0.000 description 4
108091006112 ATPases Proteins 0.000 description 3
239000011575 calcium Substances 0.000 description 3
201000011510 cancer Diseases 0.000 description 3
230000010261 cell growth Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
210000002950 fibroblast Anatomy 0.000 description 3
239000012530 fluid Substances 0.000 description 3
238000000338 in vitro Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
210000004881 tumor cell Anatomy 0.000 description 3
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
208000026310 Breast neoplasm Diseases 0.000 description 2
102100029974 GTPase HRas Human genes 0.000 description 2
101000584633 Homo sapiens GTPase HRas Proteins 0.000 description 2
240000005979 Hordeum vulgare Species 0.000 description 2
235000007340 Hordeum vulgare Nutrition 0.000 description 2
GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
108700020796 Oncogene Proteins 0.000 description 2
239000002246 antineoplastic agent Substances 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
235000009508 confectionery Nutrition 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000000855 fermentation Methods 0.000 description 2
230000004151 fermentation Effects 0.000 description 2
239000012467 final product Substances 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
-1 flavorings Substances 0.000 description 2
235000003599 food sweetener Nutrition 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
238000001802 infusion Methods 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000000977 initiatory effect Effects 0.000 description 2
230000005445 isotope effect Effects 0.000 description 2
230000000155 isotopic effect Effects 0.000 description 2
238000002156 mixing Methods 0.000 description 2
231100000219 mutagenic Toxicity 0.000 description 2
230000003505 mutagenic effect Effects 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
238000001556 precipitation Methods 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
230000001105 regulatory effect Effects 0.000 description 2
239000012266 salt solution Substances 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
239000003765 sweetening agent Substances 0.000 description 2
230000004614 tumor growth Effects 0.000 description 2
230000000381 tumorigenic effect Effects 0.000 description 2
239000003643 water by type Substances 0.000 description 2
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
206010006187 Breast cancer Diseases 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
241000195493 Cryptophyta Species 0.000 description 1
230000010190 G1 phase Effects 0.000 description 1
241000282412 Homo Species 0.000 description 1
235000008694 Humulus lupulus Nutrition 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
230000018199 S phase Effects 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
210000004102 animal cell Anatomy 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
229960005070 ascorbic acid Drugs 0.000 description 1
235000010323 ascorbic acid Nutrition 0.000 description 1
239000011668 ascorbic acid Substances 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000031018 biological processes and functions Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
239000006172 buffering agent Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
230000022131 cell cycle Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
230000008859 change Effects 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000000460 chlorine Substances 0.000 description 1
229910052801 chlorine Inorganic materials 0.000 description 1
208000029742 colonic neoplasm Diseases 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
230000001186 cumulative effect Effects 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
239000000824 cytostatic agent Substances 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
239000012526 feed medium Substances 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
235000013305 food Nutrition 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
238000005194 fractionation Methods 0.000 description 1
230000035784 germination Effects 0.000 description 1
239000003102 growth factor Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000036541 health Effects 0.000 description 1
238000001794 hormone therapy Methods 0.000 description 1
230000000887 hydrating effect Effects 0.000 description 1
GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
230000037427 ion transport Effects 0.000 description 1
230000001665 lethal effect Effects 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000036210 malignancy Effects 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
239000012528 membrane Substances 0.000 description 1
230000009456 molecular mechanism Effects 0.000 description 1
230000035772 mutation Effects 0.000 description 1
239000008239 natural water Substances 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
231100001221 nontumorigenic Toxicity 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
235000015205 orange juice Nutrition 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
238000001959 radiotherapy Methods 0.000 description 1
239000002994 raw material Substances 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000010992 reflux Methods 0.000 description 1
230000007363 regulatory process Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
241000894007 species Species 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
238000011477 surgical intervention Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
235000019527 sweetened beverage Nutrition 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
230000005748 tumor development Effects 0.000 description 1
231100000588 tumorigenic Toxicity 0.000 description 1
238000009423 ventilation Methods 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000000341 volatile oil Substances 0.000 description 1
239000002699 waste material Substances 0.000 description 1
238000005303 weighing Methods 0.000 description 1
239000000080 wetting agent Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

LU88175A 1991-10-31 1992-09-24 Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer LU88175A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU913437A HU208084B (en)	1991-10-31	1991-10-31	Process for producing compositions suitable for curing tumorous diseases

Publications (1)

Publication Number	Publication Date
LU88175A1 true LU88175A1 (fr)	1993-03-15

Family

ID=10964023

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU88175A LU88175A1 (fr)	1991-10-31	1992-09-24	Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer

Country Status (22)

Country	Link
US (1)	US5855921A (de)
JP (1)	JP3569916B2 (de)
KR (1)	KR100253874B1 (de)
CN (1)	CN1045162C (de)
AT (1)	AT402692B (de)
BE (1)	BE1006186A3 (de)
CA (1)	CA2122612C (de)
CH (1)	CH685282A5 (de)
CZ (1)	CZ282379B6 (de)
DE (1)	DE4232465B4 (de)
DK (1)	DK170832B1 (de)
ES (1)	ES2077530B1 (de)
FI (1)	FI114010B (de)
FR (1)	FR2683148B1 (de)
GB (1)	GB2276086B (de)
HU (1)	HU208084B (de)
IT (1)	IT1255390B (de)
LU (1)	LU88175A1 (de)
NL (1)	NL194664C (de)
NO (1)	NO307031B1 (de)
SE (1)	SE513624C2 (de)
WO (1)	WO1993008794A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995018545A1 (en) *	1994-01-06	1995-07-13	Hyd Kutató-Fejlesztó Ktf.	Food products for preventing development of diseases and process for preparing same
HU214593B (hu) *	1994-03-23	1998-06-29	HYD Kutató-Fejlesztő Kft.	Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) *	1994-08-04	1996-02-08	Bogdahn Ulrich Prof	Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) *	1995-04-20	2000-01-28	László Kótai	Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) *	1995-09-13	1997-07-10	Николаева Ирина Сергеевна	Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en)	2000-03-10	2002-09-03	General Cosmetics Corporation	Pain relief composition and method of relieving pain
HU226984B1 (en) *	2001-12-12	2010-04-28	Hyd Kutato Fejlesztoe Kft	Medical and food products for treating diabetes mellitus and process for producing thereof
WO2003068919A2 (en) *	2002-02-12	2003-08-21	The Regents Of The University Of California	Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
WO2004011426A2 (en)	2002-07-30	2004-02-05	The Regents Of The University Of California	Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
AU2002321678A1 (en) *	2002-09-09	2004-03-29	Boros Béla	Oxygen-enriched water, treated within a magnetic field and heavy water
ATE415486T1 (de) *	2002-09-13	2008-12-15	Univ California	Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese
AU2003291731B2 (en)	2002-11-04	2009-09-10	The Regents Of The University Of California	Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) *	2003-04-17	2004-11-11	Internatl Scient:Kk	重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) *	2003-05-23	2005-10-28	Ioan Nedelcu	Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) *	2003-07-03	2007-08-28	The Regents Of The University Of California	Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) *	2003-08-13	2006-02-28	Institutul Oncologic Profesor Dr. Al. Trestioreanu	Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en)	2003-11-25	2005-09-15	The Regents Of The University Of California	Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) *	2004-01-23	2005-08-04	Igor Anatolievich Pomytkin	Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en)	2004-02-20	2005-12-01	Univ California	Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) *	2004-04-13	2005-10-13	Giampapa Vincent C	Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) *	2004-06-03	2005-12-15	Kunihiro Seki	低重水素濃度食品の生産装置
RO121676B1 (ro) *	2004-08-18	2008-02-28	Institutul Oncologic "Prof.Dr. Al. Trestioreanu"	Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
EP1845805B1 (de) *	2005-02-08	2012-11-07	Woodford Associates Limited	Mit 1h2 16o versetzter softdrink
SI1846546T1 (sl) *	2005-02-08	2011-07-29	Woodford Associates Ltd	Alkoholna pijača, obogatena z 1H216O
EA012881B1 (ru) *	2005-03-05	2009-12-30	Сергей Павлович Соловьёв	Косметическая композиция с повышенным содержаниемho
JP2008533003A (ja) *	2005-03-11	2008-08-21	ヴァーダコンサルティングリミテッド	製薬用軽水、治療用組成物及びその方法
JP2008533005A (ja) *	2005-03-11	2008-08-21	ヴァーダコンサルティングリミテッド	生物学的活性物質の皮内的、経皮的又は経粘膜的送達のための方法
EA012822B1 (ru) *	2005-03-11	2009-12-30	Вада Консалтинг Лимитед	Композиции для дезинфекции поверхностей неодушевленных предметов
RU2275920C1 (ru) *	2005-04-01	2006-05-10	Игорь Анатольевич Помыткин	Способ лечения новообразований
RU2287324C1 (ru) *	2005-04-29	2006-11-20	Тамази Владимирович Баззаев	Мазь для лечения ожоговых ран
US20060251576A1 (en) *	2005-05-03	2006-11-09	The Regents Of The University Of California	Methods for measuring cholesterol metabolism and transport
TW200711660A (en) *	2005-06-10	2007-04-01	Univ California	Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
US20080292719A1 (en) *	2005-12-12	2008-11-27	Igor Anatolievich Pomytkin	Method of Treating Metabolic Syndrome
US20080292718A1 (en) *	2005-12-12	2008-11-27	Igor Anatolievich Pomytkin	Method for Suppression Appetite and Food Intake
WO2007069933A1 (en) *	2005-12-12	2007-06-21	Vada Consulting Limited	Method for decreasing postprandial glucose excursion
HUP0900231A2 (hu) *	2009-04-16	2010-11-29	Hyd Rakkutato Es Gyogyszerfejlesztoe Kft	Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE102009017966A1 (de)	2009-04-21	2010-11-04	Renate Rohlf	Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) *	2009-08-21	2014-02-25	Deuteria Beverages, Llc	Alcoholic compositions having a lowered risk of acetaldehydemia
JP6110846B2 (ja) *	2011-05-27	2017-04-05	ブリストル−マイヤーズスクイブカンパニーＢｒｉｓｔｏｌ−ＭｙｅｒｓＳｑｕｉｂｂＣｏｍｐａｎｙ	Ｃ型肝炎ウイルス阻害剤としての重水素が導入されたトリペプチド
HUP1100290A2 (en)	2011-06-01	2012-12-28	Hyd Rakkutato Es Gyogyszerfejlesztoe Kft	Combination compositions for the treatment of proliferative diseases
JP2014526685A (ja)	2011-09-08	2014-10-06	ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア	代謝流量測定、画像化、および顕微鏡法
JP6294233B2 (ja)	2011-12-07	2018-03-14	グラクソスミスクラインエルエルシー	全身骨格筋量の定量方法
HUP1200552A2 (en)	2012-09-21	2014-04-28	Hyd Rakkutato Es Gyogyszerfejlesztoe Kft	Pharmaceutical compositions for the treatment of high blood pressure
WO2014088441A1 (en) *	2012-12-03	2014-06-12	Igor Anatolievich Pomytkin	Food for the dietary management of burnout
US9134319B2 (en)	2013-03-15	2015-09-15	The Regents Of The University Of California	Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) *	2013-09-03	2013-12-25	大连世纪新源技术开发有限公司	超轻水多肽化妆品及其制备方法
WO2016001643A1 (en) *	2014-06-30	2016-01-07	Mitochondrial Substrate Invention Limited	Nutrients solutions for enhancement of cognitive function
RU2601046C1 (ru) *	2015-07-29	2016-10-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ")	Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
EP3515571B1 (de) *	2016-09-21	2026-01-07	Botanical Water Technologies IP Ltd	Isotopenzusammensetzungen
AU2018400230B2 (en)	2018-01-02	2024-06-13	Botanical Water Technologies Ip Ltd	Isotopic compositions II
WO2019174659A1 (de)	2018-03-15	2019-09-19	Karl Bau Gmbh	Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) *	2020-12-30	2021-05-18	江苏奥特泉超轻水饮料有限公司	一种低氘氢水及其制备方法及应用
CN120078803A (zh) *	2025-03-05	2025-06-03	江苏睿景生物技术有限公司	低氘水对肿瘤细胞生长抑制的作用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3807960A (en) *	1969-08-04	1974-04-30	V Thayer	Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) *	1977-02-28	1978-09-19	Yamanouchi Pharmaceut Co Ltd	Micellar preparation for rectal infusion
JPS56141822A (en) *	1980-04-07	1981-11-05	Hitachi Ltd	Method for separating and recovering hydrogen isomer
US4411798A (en) *	1980-05-27	1983-10-25	Standard Oil Company	Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) *	1983-09-23	1985-11-22	Ionescu Pantelimon Dumitru	Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
GB8705780D0 (en) *	1987-03-11	1987-04-15	Norsk Hydro As	Anticancer compounds
DE3717883A1 (de) *	1987-05-27	1988-12-15	Schiwa Gmbh	Verfahren und anordnung zur herstellung von physiologischen loesungen
AU1966188A (en) *	1987-08-07	1989-03-09	Mallinckrodt, Inc.	Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL85312A (en) *	1988-02-03	1991-08-16	Israel State	Injectable pharmaceutical compositions having improved stability
US4931154A (en) *	1989-07-17	1990-06-05	Southwestern Analytical Chemicals, Inc.	Production of metal borohydrides and organic onium borohydrides
US5223269A (en) *	1989-08-31	1993-06-29	Andrejs Liepins	Methods and composition for the treatment of hypertension

1991
- 1991-10-31 HU HU913437A patent/HU208084B/hu unknown
1992
- 1992-09-24 LU LU88175A patent/LU88175A1/fr unknown
- 1992-09-24 BE BE9200837A patent/BE1006186A3/fr not_active IP Right Cessation
- 1992-09-25 FR FR929211456A patent/FR2683148B1/fr not_active Expired - Lifetime
- 1992-09-28 KR KR1019920017662A patent/KR100253874B1/ko not_active Expired - Lifetime
- 1992-09-28 NL NL9220026A patent/NL194664C/nl not_active IP Right Cessation
- 1992-09-28 AT AT0902992A patent/AT402692B/de not_active IP Right Cessation
- 1992-09-28 IT ITMI922233A patent/IT1255390B/it active IP Right Grant
- 1992-09-28 CH CH2033/93A patent/CH685282A5/de not_active IP Right Cessation
- 1992-09-28 US US08/211,941 patent/US5855921A/en not_active Expired - Lifetime
- 1992-09-28 CN CN92110624A patent/CN1045162C/zh not_active Expired - Lifetime
- 1992-09-28 CZ CZ941020A patent/CZ282379B6/cs not_active IP Right Cessation
- 1992-09-28 GB GB9408654A patent/GB2276086B/en not_active Expired - Lifetime
- 1992-09-28 ES ES09350011A patent/ES2077530B1/es not_active Expired - Fee Related
- 1992-09-28 DE DE4232465A patent/DE4232465B4/de not_active Expired - Lifetime
- 1992-09-28 JP JP50829793A patent/JP3569916B2/ja not_active Expired - Lifetime
- 1992-09-28 WO PCT/HU1992/000036 patent/WO1993008794A1/en not_active Ceased
- 1992-09-28 CA CA002122612A patent/CA2122612C/en not_active Expired - Lifetime
1994
- 1994-04-25 SE SE9401406A patent/SE513624C2/sv not_active IP Right Cessation
- 1994-04-29 NO NO941590A patent/NO307031B1/no not_active IP Right Cessation
- 1994-04-29 FI FI941979A patent/FI114010B/fi not_active IP Right Cessation
- 1994-05-02 DK DK050094A patent/DK170832B1/da not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1045162C (zh)	1999-09-22
NO941590L (de)	1994-06-23
SE513624C2 (sv)	2000-10-09
GB2276086A (en)	1994-09-21
KR100253874B1 (ko)	2000-04-15
ITMI922233A1 (it)	1994-03-28
GB2276086B (en)	1995-09-27
IT1255390B (it)	1995-10-31
JPH08501275A (ja)	1996-02-13
FR2683148B1 (fr)	1994-09-09
HU208084B (en)	1993-08-30
DE4232465A1 (de)	1993-05-06
ITMI922233A0 (it)	1992-09-28
FI941979L (fi)	1994-06-29
BE1006186A3 (fr)	1994-06-07
CA2122612C (en)	2003-02-04
WO1993008794A1 (en)	1993-05-13
FI114010B (fi)	2004-07-30
NO307031B1 (no)	2000-01-31
NL9220026A (nl)	1994-09-01
AT402692B (de)	1997-07-25
CN1071836A (zh)	1993-05-12
ES2077530A1 (es)	1995-11-16
DE4232465B4 (de)	2008-11-06
NL194664C (nl)	2002-11-04
HU913437D0 (en)	1992-01-28
GB9408654D0 (en)	1994-07-20
FR2683148A1 (fr)	1993-05-07
CA2122612A1 (en)	1993-05-13
NL194664B (nl)	2002-07-01
KR930007461A (ko)	1993-05-20
JP3569916B2 (ja)	2004-09-29
US5855921A (en)	1999-01-05
FI941979A0 (fi)	1994-04-29
NO941590D0 (de)	1994-04-29
ES2077530B1 (es)	1996-07-01
ATA902992A (de)	1996-12-15
DK170832B1 (da)	1996-02-05
SE9401406D0 (sv)	1994-04-25
SE9401406L (sv)	1994-06-07
CH685282A5 (de)	1995-05-31
CZ282379B6 (cs)	1997-07-16
CZ102094A3 (en)	1994-12-15

Publication	Publication Date	Title
BE1006186A3 (fr)	1994-06-07	Produits pharmaceutiques pour guerir des maladies tumorales et procede pour les preparer.
JP2008110996A (ja)	2008-05-15	体脂肪低減用組成物
KR20210152670A (ko)	2021-12-16	녹용 유산균 발효물을 유효성분으로 포함하는 근육 질환 또는 근육 손상의 예방, 개선 또는 치료용 조성물
EP1147167A1 (de)	2001-10-24	Verfahren zur gewinnung von einem mit hydroxyoctadecadiensäuren (hode) oder ihren estern angereicherten öl aus einem linolsäure oder ihre ester enthaltenden ölartigen gemisch
FR2620907A1 (fr)	1989-03-31	Additif a base de magnesium pour substances nutritives, alimentaires et medicaments
JP2013535415A (ja)	2013-09-12	インスリン抵抗性の治療のための重水素減少水の使用
JPH07123928A (ja)	1995-05-16	家禽疾病予防剤及び家禽用飼料
WO2014045072A2 (en)	2014-03-27	Pharmaceutical compositions for the treatment of hypertension
CA2065032A1 (fr)	1991-12-23	Lyophilisat de potiron doux hybride et medicaments le contenant
US20060122261A1 (en)	2006-06-08	[method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
JP4847799B2 (ja)	2011-12-28	新規微生物、および新規カロテノイドの製造方法
KR102658030B1 (ko)	2024-04-16	탈염 함초 추출물 또는 이의 분획물을 포함하는 골 질환 또는 갱년기 질환 예방, 치료 또는 개선용 조성물 및 이의 제조 방법
EP1219615A2 (de)	2002-07-03	Verfahren zur Extraktion von Flavon-Gemischen, die dabei erhaltenen Gemische sowie deren Verwendung in Dermokosmetika, Ernährung und Pharmazeutika
MXPA96003241A (en)	1998-02-01	Pharmaceutical products to cure tumor diseases and procedure for its preparation
CN120392711A (zh)	2025-08-01	羟基酪醇在制备延缓和/或改善生殖机能衰老现象的产品中的应用
CN109364050A (zh)	2019-02-22	艾地苯醌在制备治疗肺动脉高压药物中的应用
US20060105965A1 (en)	2006-05-18	Method for enhancing energy levels and reducing the effects of stress using nutraceutical formulations
KR20190082434A (ko)	2019-07-10	숙취해소용 음료 조성물의 제조방법 및 이에 의하여 제조된 숙취해소용 음료 조성물
JP2009155291A (ja)	2009-07-16	ストレス性脱毛予防改善育毛剤
WO2021156145A1 (en)	2021-08-12	Adonirubin and dha for heart health
FR2499855A1 (fr)	1982-08-20	Nouvelles substances a action carcinostatique et immuno-stimulante, procede pour les preparer a partir de bacteries du genre fusobacterium, et agent carcinostatique contenant de telles substances
KR20050104092A (ko)	2005-11-02	골성장촉진활성을 갖는 지사노사이드 및 이를 함유하는기능성 식품 및 약학적 제제
Fernandez-Pato et al.	0	ICES 90 CM 1990/F: 27 MARICULTURE COMMITTEE
JP2006327983A (ja)	2006-12-07	疲労回復剤および疲労回復用飲食品
BE723288A (de)	1969-04-01